23rd Jan 2025 15:52
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:
----------
PensionBee Group PLC - London-based online pension provider - Increases assets under administration by 34% on-year to GBP5.8 billion at December 31 from GBP4.4 billion, with growth driven by strong net flows from new and existing customers, and supportive markets. Revenue for the fourth quarter rises on-year by 38% to GBP9 million from GBP7 million, and annual run rate revenue rises 36% to GBP38 million from GBP28 million the prior year. Says the retention rate for customers and AuA are both greater than 95%. 2024 revenue rises 39% to GBP33 million from GBP24 million the prior year and the firm achieves breakeven adjusted earnings before interest, tax, depreciation and amortisation of GBP0 million compared to an GBP8 million loss the prior year. Grows cost base in 2024 by 2% to GBP33 million from GBP32 million in 2023. Chief Executive Romi Savova says: "We continued to execute on our growth strategy, reaching GBP5.8 billion in assets under administration on behalf of 265,000 invested customers."
----------
Animalcare Group PLC - York, England-based supplier of veterinary pharmaceutical products - Shares rise 3.5% to 248.50 pence in London on Thursday afternoon as it reports sales growth across all three market segments for 2024. Anticipates full-year revenue increasing by around 4.9% to GBP74.2 million from GBP70.7 million the year prior. Highlights strength of Daxocox brand, which records double-digit increase in sales. Expects underlying earnings before interest, tax, depreciation and amortisation to be in line with market expectations and the prior year's figure of GBP11.6 million excluding Identicare. Says this reflects healthy gross margins and targeted selling, general and administrative spend. Net debt position grows at year-end to GBP11.5 million from GBP1.2 million in 2023, but says its strong financial platform enables it to pursue both organic and inorganic opportunities. Chief Executive Jenny Winter comments: "We are delighted to report positive trading performance for the full year, in line with market expectations. Strategically, 2024 has been transformative for our business with the disposal of Identicare Ltd and the sale of our minority stake in STEM Animal Health Inc. supporting our expansion into new attractive markets".
----------
Nexus Infrastructure PLC - Braintree, England-based provider of civil engineering and infrastructure services to the UK housebuilding sector - Reports revenue in line with market expectations, down 36% to GBP56.7 million in the 12 months to September 30, from GBP88.7 million the prior year. Pretax loss narrows over the period to GBP2.8 million from GBP8.5 million and cost of sales reduces on-year by 40% to GBP49.0 million from GBP82.7 million. Grows year-end order book by 12% to GBP51.6 million from GBP46.0 million in 2023. Proposes a final dividend of 2.0p, bringing the total for the year to 3.0p, flat with 2023. Adds that the UK government housebuilding ambitions should help to improve confidence in the sector during 2025. Chief Executive Charles Sweeney says: "FY24 has been a year of progress for Nexus Infrastructure, demonstrating resilience in a challenging market. We have focussed on delivering on our core strategic objectives and have seen progression across all, strengthening our foundations and positioning us well for future growth".
----------
ProBiotix Health PLC - Wakefield, England-based life sciences business - Reports increase in net sales for 2024 by 13% to GBP1.9 million from GBP1.7 million the prior year. Gross profit rises 15% to GBP1 million from GBP872,000 over the same period. Says 2024 trading has been "highly satisfactory", driven by extending market reach coupled with increasing customer awareness of products. Narrows earnings before interest, tax, depreciation and amortisation loss on-year to GBP568,000 from GBP709,000 owing to sales growth, cost control, focusing on product mix and negotiating lower costs with manufacturers. Notes continued focus on US market, driven by ongoing consumer movement of healthy ageing. Adds that the new financial year has started well with its first-quarter order book rising 47% to GBP620,000, fuelled by new customer orders. Chief Executive Steen Andersen comments: "We are pleased with the progress ProBiotix is making, further underlining our belief in the huge potential for LPLDL to be used as a potent preventative ingredient in maintaining normal cholesterol and blood pressure...Our focus for 2025 is to continue to build our business in the US and Europe, while maturing our activities with a view to entering the APAC region next year."
----------
Smarttech247 Group PLC - Cork, Ireland-based artificial intelligence-enhanced cybersecurity services provider - Increases on-year revenue for 12 months ended July 31 by 8.2% to EUR13.2 million from EUR12.2 million. Profit before tax narrows to EUR185,000 from EUR204,000 over the same period and cash at the period end drops by 45% to EUR3.3 million from EUR6.1 million the year prior. Notes a positive start to financial 2025 with a number of new contracts won as well as renewals from existing customers. Chief Executive Raluca Saceanu says: "These results reflect steady progress in our strategic priorities and operational capabilities. Our Managed Detection and Response platform, VisionX, continues to redefine cybersecurity standards, and its listing on the AWS Marketplace has opened doors to new opportunities. Additionally, our advancements in artificial intelligence, including the launch of Aio, our AI Assistant for VisionX, underline our commitment to leveraging cutting-edge technologies to better serve our clients."
----------
By Christopher Ward, Alliance News reporter
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.